Suchitra Chari's Profile
M.S. Pharmacology, M.Sc. Biological Sciences
Suchitra has completed her M.S. in Pharmacology at Northeastern University, Boston in addition to B. Pharmacy and M.Sc Biological Sciences from BITS Pilani. She is currently pursuing the AMWA (American Medical Writer’s Association) Essential Skills Certification course. She has around 12 years of research experience in the field of Neuropharmacology, Drug Metabolism and Biochemistry. Her education background in biology and pharmacology and work experience in neuropharmacology and drug metabolism has given her good knowledge on the drugs in the market, their benefits, side effects and interactions. Suchitra hopes to bring her expertise to the field of medical writing by providing accurate and authentic information about diseases and conditions, drugs and supplements to the general public. Her hobbies include reading, traveling, cooking and cycling.
Written / Edited / Medically Reviewed
Drug-resistant tuberculosis (TB) is a globally serious infectious disease caused by the bacterium Mycobacterium tuberculosis. It occurs as multidrug-resistant or MDR TB or in its more severe form, extensively drug-resistant or XDR TB.
High risk of heart attack, stroke, and death increase may be associated with considerable fluctuations in weight, cholesterol, blood pressure, and blood sugar even when the individuals are healthy.
Hemoglobin A1c (HbA1c) variability is a more powerful predictor of all-cause mortality in type 2 diabetic patients than the average HbA1c.
Skeletal stem cells that can grow into bone, cartilage and stroma have been isolated for the first time in humans and can aid in treating degenerative bone diseases in the future.
Tuberculosis bacteria that are resistant to treatment can now be tackled with an antibiotic that manages to stay active against the drug-resistant bacteria.